Gyre Therapeutics (GYRE) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 26.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.35% |
| Dec 31, 2025 | 26.55% |
| Jun 30, 2025 | -27.19% |
| Mar 31, 2025 | -7.73% |
| Dec 31, 2024 | -39.23% |
| Sep 30, 2024 | -32.75% |
| Jun 30, 2024 | -40.49% |
| Mar 31, 2024 | -31.27% |
| Dec 31, 2023 | -63.51% |
| Sep 30, 2023 | 36.68% |
| Jun 30, 2023 | 30.56% |
| Mar 31, 2023 | -31.60% |
| Dec 31, 2022 | -442.03% |
| Jun 30, 2022 | 143.52% |
| Mar 31, 2022 | -33.88% |
| Dec 31, 2021 | -11.64% |
| Sep 30, 2021 | 57.87% |
| Jun 30, 2021 | 29.01% |
| Mar 31, 2021 | 225.06% |
| Dec 31, 2020 | 172.12% |
| Sep 30, 2020 | -8.89% |
| Jun 30, 2020 | -2,786.18% |
| Mar 31, 2020 | 59.18% |
| Dec 31, 2019 | -57.77% |
| Sep 30, 2019 | 83.10% |
| Jun 30, 2019 | 38.13% |
| Mar 31, 2019 | 62.57% |
| Dec 31, 2018 | -27.66% |
| Sep 30, 2018 | -28.82% |
| Jun 30, 2018 | -539.31% |
| Mar 31, 2018 | 53.74% |
| Sep 30, 2017 | -20.91% |
| Jun 30, 2017 | -25.99% |
| Mar 31, 2017 | 52.02% |
| Dec 31, 2016 | 37.75% |
| Sep 30, 2016 | -34.68% |
| Jun 30, 2016 | -52.19% |
| Mar 31, 2016 | -9.75% |
| Dec 31, 2015 | -11.50% |
| Sep 30, 2015 | 16.47% |
| Jun 30, 2015 | -37.58% |
| Mar 31, 2015 | -68.07% |
| Sep 30, 2014 | 21.13% |
| Jun 30, 2014 | 30.88% |
| Mar 31, 2014 | 32.94% |
| Dec 31, 2013 | -15.12% |
| Sep 30, 2013 | 34.38% |